“Disease management” [MeSH]
“Disease management”
“Disease state management”
“Delivery of Health Care, Integrated” [MeSH]
“Comprehensive Health Care” [MeSH:NoExp]
-
“Patient Care Planning” [MeSH] NOT
“Advance Care Planning” [MeSH]
“Primary Health Care” [MeSH] NOT “Refusal to Treat” [MeSH]
“Patient Care Team” [MeSH:NoExp]
“Critical Pathways” [MeSH]
“Case Management” [MeSH]
“Continuity of Patient Care” [MeSH]
“Practice Guidelines” [MeSH]
“Guidelines” [MeSH]
“Clinical Protocols” [MeSH:NoExp]
“Patient Education” [MeSH]
“Self Care” [MeSH:NoExp]
“Reminder systems” [MeSH]
“Health Education“ [MeSH]
“Health Promotion” [MeSH:NoExp]
“Community Health Planning” [MeSH]
“Ambulatory Care” [MeSH]
(Patient OR providers) AND feedback
(Patient OR providers) AND reminder
(Patient OR providers) AND monitor$
OR/1–24
-
“Epidemiologic Research Design” [MeSH] NOT
“Sensitivity and Specificity” [MeSH]
“Clinical Trials” [MeSH:NoExp]
“Controlled Clinical Trials” [MeSH]
“Randomized Controlled Trials” [MeSH]
“Multicenter Studies” [MeSH]
-
“Epidemiologic Studies” [MeSH] NOT
“Seroepidemiologic Studies” [MeSH]
“Pilot Projects” [MeSH]
“Sampling Studies” [MeSH]
“Program Evaluation” [MeSH]
“Intervention Studies” [MeSH]
“Evaluation Studies” [MeSH:NoExp]
OR 26–36
Controlled Clinical Trial [pt]
Clinical Trial [pt]
Multicenter Study [pt]
Randomized Controlled Trial [pt]
Evaluation Studies [pt]
Meta-analysis [pt]
OR 38–43
37 OR 44
AND “Pulmonary Disease, Chronic Obstructive” [MeSH]
25 AND 45
Limit 47 to human
Limit 48 to yr 1995–2007
Limit 49 to English